Cost-effectiveness of treating latent tuberculous infection: a step towards elimination? [Editorial]
No Abstract
Document Type: Editorial
Affiliations: 1: Institute for Epidemiology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany 2: German Central Committee Against Tuberculosis, Berlin, Germany 3: Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari, Sassari, Italy 4: World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri Care and Research Institute, Tradate, Italy
Publication date: 01 December 2013
The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.
The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites
Receive new issue alert- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content